S N Nasonova Selected Research

Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)

1/2006

[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S N Nasonova Research Topics

Disease

15	Heart Failure 03/2024 - 01/2003
4	Amyloidosis 05/2023 - 01/2020
2	Transthyretin-Related Hereditary Amyloidosis 05/2023 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 05/2022 - 01/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2019 - 01/2018
2	Coronary Disease (Coronary Heart Disease) 09/2019 - 01/2005
2	Acute Kidney Injury (Acute Renal Failure) 05/2019 - 01/2018
1	Hyperemia 05/2023
1	Inflammation (Inflammations) 11/2021
1	Disease Progression 11/2021
1	Hyperuricemia 09/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Heart Injuries 01/2020
1	Infarction (Infarctions) 09/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2019
1	Hypotension (Low Blood Pressure) 01/2011
1	Ventricular Remodeling 01/2003

Drug/Important Bio-Agent (IBA)

3	Interleukin-6 (Interleukin 6)IBA 03/2024 - 11/2021
3	Prealbumin (Transthyretin)IBA 05/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 09/2019 - 01/2018
3	Valsartan (Vals)FDA Link 01/2006 - 01/2005
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2006 - 01/2003
3	Quinapril (Accupril)FDA LinkGeneric 01/2006 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 05/2023 - 05/2022
2	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2018
2	Deoxycytidine Monophosphate (DCMP)IBA 09/2019 - 01/2005
2	Angiotensin IIIBA 01/2006 - 01/2005
2	Bisoprolol (Concor)FDA LinkGeneric 01/2006 - 01/2003
2	Angiotensin Receptor AntagonistsIBA 01/2006 - 01/2006
1	Polysaccharides (Glycans)IBA 05/2023
1	Ethanol (Ethyl Alcohol)IBA 05/2023
1	Cytokine Receptor gp130IBA 03/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2022
1	Technetium Tc 99m PyrophosphateIBA 05/2022
1	CytokinesIBA 11/2021
1	DiureticsIBA 09/2021
1	Uric Acid (Urate)IBA 09/2021
1	tafamidisIBA 01/2020
1	ElementsIBA 09/2019
1	Lipocalin-2IBA 01/2018
1	A-factor (Streptomyces)IBA 01/2011
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 01/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2006
1	N 30IBA 01/2003

Therapy/Procedure

5	Therapeutics 05/2022 - 01/2003